English
English
Português
Français
English
English
Português
Français
Antimalarial Tablet
Oral antimalarial tablet combining sulfadoxine and pyrimethamine for treatment and prevention of chloroquine-resistant P. falciparum malaria.
Each tablet contains: Sulfadoxine – 500 mg, Pyrimethamine – 25 mg
Colour: White, Uncoated
For treatment and prevention of chloroquine-resistant P. falciparum malaria via single oral dose.
Adults and children over 14 years/45kg: 3 tablets as single dose. Children 10-14 yrs: 2 tablets; 5-10 yrs: 1.5 tablets; 2-5 yrs: 1 tablet; below 2 yrs: 0.5 tablet, as single dose. Do not repeat within 7 days.
Note: As per Doctors Advice
1×3 Tablets Blister Strip
One Inner Carton with Insert
Outer Carton: 20 Inner Cartons in One Outer Carton.
7-Ply Export Shipper
Oral use only. Swallow tablets whole with water, preferably after food.
36 Months
Store below 25°C in a cool, dry place, protected from light and moisture.
Contraindicated in sulfonamide hypersensitivity, megaloblastic anemia, and first trimester of pregnancy. Not recommended for infants under 2 months.
Nausea, vomiting, abdominal pain, headache, dizziness; rare but serious hypersensitivity reactions including Stevens-Johnson syndrome, toxic epidermal necrolysis, and blood dyscrasias (agranulocytosis, thrombocytopenia).
Recommended as a single-dose treatment when standard chloroquine therapy is ineffective.
Suitable for prophylaxis in individuals travelling to or residing in high-transmission malaria zones.
Combination of sulfadoxine and pyrimethamine acts synergistically against malaria parasites.
Just submit your details and we’ll be in touch shortly.
